Physician profile
Kevin Wright
NPI 1073615696
$2,919.55
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $435 · 2021: $466 · 2022: $1,738 · 2023: $18.09 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,200.00 | 2022 | |
| Nevro Corp. | $681.72 | 2020-2022 | |
| Ermi LLC | $177.75 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $150.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $147.50 | 2022 | |
| Si-Bone, INC. | $137.05 | 2021 | |
| Esperion Therapeutics, INC. | $125.00 | 2020 | |
| Curonix LLC | $117.77 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Horizon Therapeutics Plc | $115.90 | 2019-2020 | |
| Depuy Synthes Sales INC. | $20.19 | 2024 | Monovisc |
| Paragon 28, INC. | $18.09 | 2023 | Baby Gorilla |
| Zyla Life Sciences, INC. | $14.66 | 2019 | |
| Pacira Therapeutics, INC. | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.